Építés alatt – nem éles oldal
Belépés
Befejeződött2. fázis

Effect of Endotoxin on Alcohol Consumption

A legfontosabb adatok

Ki végzi
Yale University
Hol
New Haven (Egyesült Államok)A helyszín megnézése
Azonosító
Állapot
Befejeződött
Fázis
2. fázis
Résztvevők
27 fő vett részt
Kezdés
2022. febr. 27.
Befejezés
2024. okt. 31.
A vizsgálat típusa
Beavatkozással járó, 2 csoportAz egyik csoport placebót (hatóanyag nélküli szert) kap, összehasonlításként.
A vizsgált kezelések
  • Endotoxin
A regiszteradat frissítve
2025. november 3.

Ki vehet részt

Életkor
21 év – 65 év
Nem
Nők és férfiak
Egészséges önkéntesek
Részt vehetnek

A regiszter feltételei, szó szerint

Mind a 21 feltétel megnézéseKevesebb

Ki vehet részt

  • Age 21-65
  • Able to read and write English
  • Meets DSM-5 criteria for current (past 6 months) alcohol use disorder
  • Drinking criteria: Males - Drinks > 14 drinks per week and exceeds 4 drinks per day at least twice per week; Females -Drinks > 7 drinks per week and exceeds 3 drinks per day at least twice per week
  • Must meet drinking criteria during a consecutive 30-day period within the 90 days prior to baseline
  • Laboratory sessions will be scheduled such that subjects will not have major responsibilities on the following day which might limit drinking during the self-administration session (e.g., job interview, exam)
  • Negative urine pregnancy test for women

Ki nem vehet részt

  • A positive test result at intake appointment on urine drug screens conducted for illicit drugs, excluding cannabis
  • Past 30 day use of psychoactive drugs including anxiolytics and antidepressants
  • Women who are pregnant or nursing, or fail to use one of the following methods of birth control unless she or partner is surgically sterile or she is postmenopausal (hormone contraceptives [oral, implant, injection, patch, or ring], contraceptive sponge, double barrier [diaphragm or condom plus spermicide], or IUD)
  • Participants with any significant current medical conditions (neurological, cardiovascular [including hypertension or hypotension: sitting BP >160/100 or <90/60mmHg at baseline screening], endocrine, thyroid, renal, liver), seizures, delirium or hallucinations, or other unstable medical conditions including HIV
  • Current DSM-5 substance use disorders, other than alcohol or nicotine
  • Suicidal, homicidal or evidence of current (past 6-month) severe mental illness such as schizophrenia, bipolar disorder or major depression, or anxiety disorders
  • Subjects with medical conditions contraindicating alcohol use (e.g., liver enzymes ≥3× normal)
  • Subjects likely to exhibit clinically significant alcohol withdrawal during the study. We will exclude subjects who a) have a history of perceptual distortions, seizures, delirium, or hallucinations upon withdrawal, or b) have a score of > 8 on the Clinical Institute Withdrawal Assessment scale at intake appointments
  • Subjects >38 on the Alcohol Use Disorders Identification Test (AUDIT)
  • Subjects with recent (past 2 weeks) acute illness or vaccination
  • Subjects with >Grade 2 laboratory abnormalities on screening
  • Subjects treatment-seeking or who are currently in treatment for alcohol use
  • Participation within the past 8 weeks in other studies that involve additive blood sampling and/or interventional measures that would be considered excessive in combination with the current application
  • Subjects with resting pulse >100 at challenge

Helyszínek itt: Egyesült Államok

  • Yale School of MedicineNew Haven, Egyesült Államok

A vizsgálatról

Mit akar kideríteni a vizsgálat

For this protocol, the investigators plan to collect pilot data to examine the effect of endotoxin on drinking behavior in the human laboratory.

A vizsgálat 2 csoportja

  • EndotoxinA vizsgált kezelés

    Endotoxin (0.4ng/kg i.v.) will be administered one time during the laboratory session.

  • PlaceboPlacebo, összehasonlításként

    Administered one time during the laboratory session.

    Kezelés: Endotoxin

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
Does Endotoxin Administration Increase Alcohol Consumption in Individuals With AUD?
A regiszteradat frissítve
2025. november 3.